Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Golden Valley Development, Inc (GVDI)
Clearwater, FL, US
Golden Valley Development, Inc. operates through its subsidiaries, primarily focusing on the creation and distribution of proprietary products for both the healthcare and household consumer sectors. Noteworthy examples include Percuguard and Cutstop, which are specialized finger safety guards designed to protect fingers and thumbs from unintentional cuts caused by knives and other sharp implements. Additionally, the company provides media consulting services, where it identifies and facilitates partnerships among businesses, investors, and influential individuals in the entertainment and sports industries for the development of collaborative marketing and entertainment ventures. Golden Valley Development, Inc. was established in 2004 and is headquartered in Clearwater, Florida.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -48.46% | -46.83% | -68.10% | -68.10% | -86.60% | +737.50% | -60.59% | +857.14% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Instruments & Supplies: +7.9%—
-
EPS growth Medical - Instruments & Supplies: +16.3%+0.0% Q2'25: +200.0% (vs Q2'24)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%—
-
EBIT margin Medical - Instruments & Supplies: +13.5%—
-
ROIC Medical - Instruments & Supplies: +6.0%— Q2'25: -57.4% (vs Q2'24)
-
Share dilution Medical - Instruments & Supplies: +0.1%+0.0% Q2'25: +0.0% (vs Q2'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×— Q2'25: -14.47× (vs Q2'24)
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Carter Ransom | Chief Operating Officer, Vice President & Member of Advisory Board | — | male |
| Kevin Sorrels | Chairman of the Board, Chief Executive Officer, President, Secretary & Treasurer | — | — |
| Nikolaos Balomenos | Co-CEO & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GVDI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
